Addressing the Medical Need in CLL: How BTK Inhibitors Are Improving Outcomes

Get up to date on optimal use of BTK inhibitors in the care of your patients with CLL with an interactive on-demand Webcast and downloadable slides from a live Webinar along with expert commentaries and our BTK Inhibitor AE Management Tool.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

BeiGene, Ltd.